This inventor holds 1 USPTO granted patent. Top assignee: Chdi Foundation, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: The Innovations of Charles H. Montgomery
Introduction
Charles H. Montgomery is an accomplished inventor based in Bolton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of kynurenine-3-monooxygenase inhibitors. His work has the potential to impact various therapeutic areas.
Latest Patents
Montgomery holds a patent for "Solid forms of a kynurenine-3-monooxygenase inhibitor." This patent details the preparation and characterization of forms of 6-(3-chloro-4-cyclopropoxyphenyl)pyrimidine-4-carboxylic acid, also known as Compound I. The patent also outlines processes for manufacturing and methods for using these forms and their salts or co-crystals.
Career Highlights
Montgomery is associated with the CHDI Foundation, Inc., where he continues to advance his research and innovations. His work is crucial in the ongoing efforts to develop effective treatments for neurological disorders.
Collaborations
Montgomery has collaborated with notable colleagues, including Leticia M. Toledo-Sherman and Celia Dominguez. These partnerships enhance the research and development efforts within his field.
Conclusion
Charles H. Montgomery's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile